Early research (Phase 1)Study completedNCT02051335
What this trial is testing
Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults
Who this might be right for
Memory ImpairmentAlzheimer's Disease
AstraZeneca 27